| Metric | შპს ჯი-ი-ეს-ეი ფარმაცევტიკალს | შპს როლი | შპს თი-აი-დი ფუდს | შპს ნიუ ფარმ გრუპი |
|---|---|---|---|---|
| Growth | ||||
| Revenue | ₾3.5m₾0 | ₾5.6m₾9.1m | ₾3.2m₾3.9m | ₾5.1m₾5.2m |
| Revenue growth | — | -38.3% | -18.5% | -2.0% |
| Profitability | ||||
| EBITDA | ₾1.4m₾0 | ₾14k₾189k | ₾386k₾388k | ₾458k₾1.6m |
| EBITDA margin |
| 40.0% |
| 0.2%2.1% |
| 12.2%10.0% |
| 9.1%30.4% |
| Net profit | ₾1.5m₾0 | -₾305₾187k | ₾237k₾437k | ₾221k₾1.4m |
| Net margin | 42.8% | -0.0%2.1% | 7.5%11.2% | 4.4%26.2% |
| Balance sheet | ||||
| Total assets | ₾2.7m₾1.5m | ₾941k₾1.3m | ₾1.7m₾2.9m | ₾4.0m₾4.8m |
| Total equity | ₾2.7m₾1.2m | ₾271k₾271k | ₾346k₾320k | ₾1.1m₾1.5m |
| ROE | 54.8%0.0% | -0.1%69.0% | 68.3%136.6% | 19.6%89.7% |